ATE383163T1 - Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen - Google Patents

Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen

Info

Publication number
ATE383163T1
ATE383163T1 AT03725310T AT03725310T ATE383163T1 AT E383163 T1 ATE383163 T1 AT E383163T1 AT 03725310 T AT03725310 T AT 03725310T AT 03725310 T AT03725310 T AT 03725310T AT E383163 T1 ATE383163 T1 AT E383163T1
Authority
AT
Austria
Prior art keywords
treatment
prophylaxis
lactobacillus farciminis
digestive diseases
farciminis
Prior art date
Application number
AT03725310T
Other languages
English (en)
Inventor
Jean Fioramonti
Lionel Bueno
Vassilia Theodorou
Florence Lamine
Original Assignee
Agronomique Inst Nat Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech filed Critical Agronomique Inst Nat Rech
Application granted granted Critical
Publication of ATE383163T1 publication Critical patent/ATE383163T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03725310T 2002-03-28 2003-03-21 Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen ATE383163T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0203891A FR2837711B1 (fr) 2002-03-28 2002-03-28 Utilisation de la lactobacillus farciminis pour la prevention ou le traitement de pathologies digestives

Publications (1)

Publication Number Publication Date
ATE383163T1 true ATE383163T1 (de) 2008-01-15

Family

ID=27839273

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03725310T ATE383163T1 (de) 2002-03-28 2003-03-21 Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen

Country Status (10)

Country Link
US (2) US7294337B2 (de)
EP (1) EP1487466B1 (de)
AT (1) ATE383163T1 (de)
AU (1) AU2003227852A1 (de)
CA (1) CA2480387C (de)
DE (1) DE60318558T2 (de)
DK (1) DK1487466T3 (de)
ES (1) ES2299698T3 (de)
FR (1) FR2837711B1 (de)
WO (1) WO2003082307A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1883451B9 (de) * 2005-04-13 2011-02-09 Neuraxon Inc. Substituierte indolverbindungen mit nos-hemmender aktivität
WO2007118314A1 (en) * 2006-04-13 2007-10-25 Neuraxon, Inc. 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
FR2922450B1 (fr) * 2007-10-19 2014-06-13 Lallemand Sas Utilisation de bacteries lactique pour la prevention et/ou le traitement de pathologies cutanees
CA2705833A1 (en) * 2007-11-16 2009-05-22 Subhash C. Annedi 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
US20090163451A1 (en) * 2007-11-16 2009-06-25 Frank Porreca Methods for treating visceral pain
CA2705835A1 (en) * 2007-11-16 2009-05-22 Neuraxon, Inc. Indole compounds and methods for treating visceral pain
WO2009154463A2 (en) * 2008-06-20 2009-12-23 Stichting Top Institute Food And Nutrition Butyrate as a medicament to improve visceral perception in humans
WO2012044984A1 (en) 2010-09-30 2012-04-05 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
US20130017174A1 (en) * 2011-07-12 2013-01-17 The Board Of Trustees Of The University Of Arkansas Compositions and methods for increasing health and reducing pathogenic bacteria in animals
CN112804887A (zh) * 2018-09-26 2021-05-14 株式会社明治 线粒体功能改善剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764802A1 (fr) * 1996-12-24 1998-12-24 Standa Lab Sa Composition adsorbable renfermant des bacteries propioniques susceptible de degager du monoxyde d'azote dans le tube digestif humain ou animal
AU2296897A (en) * 1997-03-20 1998-10-20 Jean James Garreau Food products based on soybean milk and method for making same
FR2785809B1 (fr) * 1998-11-18 2001-01-12 Gervais Danone Sa Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1344458A1 (de) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. System zur Verabreichung von Probiotika

Also Published As

Publication number Publication date
US7628991B2 (en) 2009-12-08
DE60318558T2 (de) 2009-01-22
DE60318558D1 (de) 2008-02-21
WO2003082307A1 (fr) 2003-10-09
US20080085268A1 (en) 2008-04-10
EP1487466B1 (de) 2008-01-09
US7294337B2 (en) 2007-11-13
CA2480387A1 (fr) 2003-10-09
FR2837711B1 (fr) 2005-05-06
DK1487466T3 (da) 2008-05-19
CA2480387C (fr) 2013-04-23
AU2003227852A1 (en) 2003-10-13
US20050244389A1 (en) 2005-11-03
FR2837711A1 (fr) 2003-10-03
EP1487466A1 (de) 2004-12-22
ES2299698T3 (es) 2008-06-01

Similar Documents

Publication Publication Date Title
DE60129823D1 (de) Stickstoffoxid zur behandlung therapieresistenter organismen
ATE440132T1 (de) Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger
EP2081593A4 (de) Bakterielle lebendimpfstoffe zur prophylaxe oder behandlung von virusinfektionen
EP4364745A3 (de) Neuartige milchsäurebakterien und verwendung davon
DE60330889D1 (de) Botulinum toxin zur behandlung von magengeschwür und gastroösophagealen reflux
ATE383163T1 (de) Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen
ATE354585T1 (de) Antibakterielle amid-makrozyklen
SE0400355D0 (sv) New synbiotec use
PH12020551905A1 (en) C-mannoside compounds useful for the treatment of urinary tract infections
EA201100413A1 (ru) Способ лечения бактериальной инфекции
ATE456955T1 (de) Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
EP4096628C0 (de) Verwendung von 5-amino-2,3-dihydro-1,4-phthalazindion zur inhalativen behandlung von entzündlichen lungenerkrankungen
WO2021004958A3 (en) Compositions comprising bacterial strains
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
ATE495186T1 (de) Antibakterielle amid-makrozyklen iv
MX2021011183A (es) Fitoecdisonas y los derivados de las mismas para su uso en el tratamiento de la alteracion de la funcion respiratoria.
ATE392212T1 (de) Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen
ATE308895T1 (de) Behandlung von infektionen in tieren
WO2018176066A3 (en) Cord blood therapy to treat chronic disease caused by l-form bacteria
MXPA05013703A (es) Aivlosin para el tratamiento de una enfermedad causada por brachyspira pilosicoli u ornithobacterium rhinotracheale.
GB201911728D0 (en) Bacterial composistions for the treatment of disease
ATE547117T1 (de) Pharmazeutisches, oral applizierbares präparat zur behandlung von fischen, herstellungsverfahren für dieses und seine verwendung
DE602004012759D1 (de) Behandlung von fibrosen
TNSN06147A1 (en) Use of cathepsin k inhibitors for treating of severe bone loss diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties